Skip to content

Veritas Collagen Matrix Cystocele Repair Study - Postmarketing

Veritas Collagen Matrix Cystocele Repair Study - Postmarketing Protocol #CP1004

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00860912
Enrollment
94
Registered
2009-03-13
Start date
2001-12-31
Completion date
2007-05-31
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Veritas, Cystocele, Prolapse

Brief summary

The purpose of this study is to evaluate the Veritas Collagen Matrix in treating female patients with documented occurence of Pelvic Organ Prolapse as evidenced by a cystocele.

Detailed description

Surgery for cystocele repair to be performed. Native tissue repair to be randomized versus reinforcement with Collagen matrix .

Interventions

surgical/reinforcing material

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

collagen graft reinforcement

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient is equal or greater than 18 years old * Female * Meets follow-up evaluation time frame * Understands the nature of the procedure and has provided written informed consent * Is scheduled to undergo vaginal pelvic reconstructive surgery * Has \> 2nd degree midline cystocele

Exclusion criteria

* Presence of severe mucosal ulceration * Previous pelvic organ prolapse surgery using an implant that will affect the use of the VCM or affect the outcome of the study * Allergy to bovine material * Severe mucosal atrophy * Shortened vaginal length as determined by Investigator * Pregnant or intends to become pregnant during study * Has a UTI * Has vault prolapse \< 2nd degree cystocele

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the ability of the VCM to treat pelvic organ prolapse as demonstrated by improvement of cystocele as measured by a comparison of POP-Q scores pre and post surgery2 yearsprolapse degree on pelvic exam

Secondary

MeasureTime frameDescription
To evaluate patient satisfaction as measured by a comparison of Quality of Life questions at baseline and post surgery2 yearssubjective satisfaction

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026